Kategorie: Literatur

Campion EW et al.: Watched by Apple. N Engl J Med 381 (2019):1964-1965
DOI: 10.1056/NEJMe1913980

Kommentar zur Veröffentlichung der Apple Heart Study

After taking over media, social communication, and the consumer economy, the forces of digital innovation are moving into the worlds of medical practice and medical research. Both the power and the limitations of digital innovation in medicine are evident in a report by Perez and colleagues, “Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation,” published in this issue of the Journal.

Värmland führt als erste Region in Schweden einen digitalen Versorgungsweg für die Arrhythmie-Diagnostik ein (Pressemitteilung Zenicor 27.09.2018)

Die Provinz Värmland als Leistungserbringer und Kostenträger der Gesundheitsversorgung in der Region hat 2018 gemeinsam mit der Zenicor Medical Systems AB ein Modell für einen effektiveren Behandlungspfad zur Arrhythmie-Diagnostik entwickelt. Alle Gesundheitszentren der Region werden den Service anbieten, um Wartezeiten zu verkürzen und die erforderlichen Besuche in der Praxis zu reduzieren.
„Digitaler Versorgungsweg für die Arrhythmie-Diagnostik in Värmland“ weiterlesen

NICE Diagnostics guidance: Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care. online 8.5.2019

Das National Institute for Health and Care Excellence (NICE) in Großbritannien ist eines der Vorbilder des deutschen IQWIG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen),

Online: www.nice.org.uk/guidance/dg35 oder Download als PDF (169 kb)

Recommendations
1.1 There is not enough evidence to recommend the routine adoption of lead-I electrocardiogram (ECG) devices (imPulse, Kardia Mobile, MyDiagnostick and Zenicor-ECG) to detect atrial fibrillation when used for single time point testing in primary care for people with signs or symptoms of the condition and an irregular pulse. Further research is recommended to show how using lead-I ECG devices in this way affects:
the number of people with atrial fibrillation detected, compared with current practice (see section 6.1) and
primary and secondary care services, particularly how ECGs generated by the devices would be interpreted in practice, including staff time needed to interpret the ECG traces and associated costs (see section 6.2).
1.2 Centres currently using these devices for this indication are encouraged to take part in research and data collection (see sections 6.1 and 6.2).

Bose R: The Democratization of Diagnosis: Bringing the Power of Medical Diagnosis to the Masses. EClinicalMedicine 8 (2019) 6-7
https://doi.org/10.1016/j.eclinm.2019.03.004
„Die Demokratisierung der Diagnose“ weiterlesen